About
Cancer Genomic Profiling
Areas of Focus
Categories
Genetics & Genomics
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
0
As Collaborator
8
Total Enrollment
1,416
By Phase
NA: 1PHASE2: 2
By Status
UNKNOWN: 6NOT_YET_RECRUITING: 2
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT06709274Collaborator
Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC
NANot yet recruiting
342 participants
Started: Nov 30, 2024 · Completed: Jan 31, 2032
NCT06083779Collaborator
Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics
N/AUnknown
216 participants
Started: Aug 1, 2023 · Completed: Apr 30, 2024
NCT05693987Collaborator
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)
N/AUnknown
248 participants
Started: Nov 1, 2022 · Completed: Apr 30, 2023
NCT05594381Collaborator
A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.
PHASE2Not yet recruiting
90 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2025
NCT05693974Collaborator
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)
N/AUnknown
130 participants
Started: Oct 1, 2022 · Completed: Apr 30, 2023
Locations (1)
Headquarters
Toronto, ON, Canada
Map
Loading map...